Feraheme
Approval
- What happened
The FDA approved Feraheme for iron deficiency anemia in adults with chronic kidney disease.
- Why it matters
Because the particles show up on MRI and stay in the blood a long time, researchers have also examined it as a contrast agent for scans.
DrugBank, ferumoxytol- How far from your life
Approved or on sale
Ferumoxytol (Feraheme) is on step 4 of 5. You can get it now, though it may not be common yet.
- Source
“FDA Approves Feraheme to Treat Iron Deficiency Anemia in Adult Chronic Kidney Disease Patients”Drugs.com approval history
The bigger picture
More on Feraheme
On step 4 of 5: Approved or on sale. Everything we track on it
- ApprovalCompany-reported
AMAG said the FDA had approved Feraheme for all eligible adults with iron deficiency anemia, not only those with kidney disease.
Drugs.com approval history - Safety
The FDA added a boxed warning, its strongest kind, because serious and sometimes fatal allergic reactions can occur, and changed the instructions for giving it.
US FDA via Drugs.com, 30 Mar 2015